Exciting news in the tech world as CultureAI announces a significant funding round of $10,000,000! CultureAI is known for its cutting-edge Human Risk Management Platform, which allows businesses to identify and address potential security risks within their workforce. With this recent injection of capital, CultureAI aims to further develop its platform and expand its capabilities to help companies strengthen resilience against phishing attacks, enhance SaaS security, reduce data loss through generative AI, and much more. By empowering security teams to efficiently manage employee security risks in one integrated platform, CultureAI is at the forefront of revolutionizing how businesses approach cybersecurity. The company's commitment to enhancing digital safety and mitigating human-related risks in the workplace makes this funding round a significant milestone in their journey towards creating a safer and more secure digital environment for organizations worldwide.
CultureAI Secures $10 Million in Series A Funding to Revolutionize Human Risk Management in the Workplace
Recently funded · $10.0M Series aComputer and Network Security
Get the full CultureAI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)